EXPERIMENTAL TESTING OF THE MODIFIED METHOD OF INTRAVITREAL INJECTION IN THE RABBIT EYE

A. Kalatanova, A. Katelnikova, M. Makarova, V. Makarov
{"title":"EXPERIMENTAL TESTING OF THE MODIFIED METHOD OF INTRAVITREAL INJECTION IN THE RABBIT EYE","authors":"A. Kalatanova, A. Katelnikova, M. Makarova, V. Makarov","doi":"10.30895/1991-2919-2018-8-2-109-114","DOIUrl":null,"url":null,"abstract":"the article describes theoretical foundations and successful experimental testing of a modified method of intravitreal injection (ivi) in the rabbit eye performed in the laboratory. the method needed modification because preoperative preparation described in available guidelines on ivi requires the use of medicines that are not suitable for use in vivariums in the russian federation. the ivi procedure for rabbits was modified by using an anesthetic regime reproducible in russia and available eye preparations. the anesthetics used were Zoletil 50 («virbac», france) at a dose of 1.1 mg/kg and rometar («Bioveta, a.s.», czech republic) at a single intravenous dose of 5.6 mg/kg. additional analgesia was achieved by a single intramuscular injection of Ketonal («lek d.d.», Slovenia) at a dose of 5 mg/kg. the local anesthetic used was inokain eye drops («promed exports pvt. ltd.», india), the antiseptic used was Betadine (JSc «eGiS pharmaceutical plant», hungary) diluted with water in the proportion of 1:10. the results of clinical examination of animals following ivi performed by lab researchers during unassisted skill training were analysed, and the results of assessment of adverse reactions associated with ivi were expressed as scores and reflected in primary records. the suggested method demonstrated good reproducibility and, therefore, may be recommended for use in preclinical studies of ophthalmic drug products in russia.","PeriodicalId":22286,"journal":{"name":"The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30895/1991-2919-2018-8-2-109-114","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

the article describes theoretical foundations and successful experimental testing of a modified method of intravitreal injection (ivi) in the rabbit eye performed in the laboratory. the method needed modification because preoperative preparation described in available guidelines on ivi requires the use of medicines that are not suitable for use in vivariums in the russian federation. the ivi procedure for rabbits was modified by using an anesthetic regime reproducible in russia and available eye preparations. the anesthetics used were Zoletil 50 («virbac», france) at a dose of 1.1 mg/kg and rometar («Bioveta, a.s.», czech republic) at a single intravenous dose of 5.6 mg/kg. additional analgesia was achieved by a single intramuscular injection of Ketonal («lek d.d.», Slovenia) at a dose of 5 mg/kg. the local anesthetic used was inokain eye drops («promed exports pvt. ltd.», india), the antiseptic used was Betadine (JSc «eGiS pharmaceutical plant», hungary) diluted with water in the proportion of 1:10. the results of clinical examination of animals following ivi performed by lab researchers during unassisted skill training were analysed, and the results of assessment of adverse reactions associated with ivi were expressed as scores and reflected in primary records. the suggested method demonstrated good reproducibility and, therefore, may be recommended for use in preclinical studies of ophthalmic drug products in russia.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
改进的兔眼玻璃体内注射方法的实验研究
本文介绍了一种改进的兔眼玻璃体内注射(ivi)方法的理论基础和成功的实验测试。该方法需要修改,因为现有ivi指南中描述的术前准备需要使用在俄罗斯联邦不适合在体内使用的药物。家兔ivi程序通过使用在俄罗斯可重复的麻醉制度和可用的眼部制剂进行修改。所使用的麻醉剂是唑来替尔50 (" virbac ",法国),剂量为1.1 mg/kg,罗米他(" Bioveta, a.s. ",捷克共和国),单次静脉注射剂量为5.6 mg/kg。通过单次肌肉注射酮酮(“lek d.d.”,斯洛文尼亚),剂量为5 mg/kg,实现了额外的镇痛。使用的局部麻醉剂为inokain滴眼液(“promed exports pvt. ltd.”,印度),使用的防腐剂为倍他定(JSc“eGiS制药厂”,匈牙利),用水按1:10的比例稀释。分析实验室研究人员在无辅助技能训练期间对ivi后动物进行的临床检查结果,并以分数表示与ivi相关的不良反应评估结果,并反映在原始记录中。所建议的方法具有良好的重复性,因此可推荐用于俄罗斯眼科药品的临床前研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Analysis of the Medicinal Products for Human Use Authorised in the Russian Federation Diffusion-Ordered NMR Spectroscopy Application for Analysis of Polysaccharides Determination of Heavy Metals, Arsenic, and Aluminum Content in Pumpkin Seed Herbal Substance and Native Products, by Inductively Coupled Plasma Mass Spectrometry The Use of Spectroscopic Methods for Structural Elucidation of Individual Secondary Metabolites Isolated from the Aerial Parts of Corydalis bracteata NMR as Used in the Russian and Foreign Pharmacopoeias for Quality Control of Medicinal Products
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1